BAY 1000394 for MCL-1-, MYC-, and CCNE1-Amplified Tumors
Status:
Withdrawn
Trial end date:
2023-05-01
Target enrollment:
Participant gender:
Summary
This research study is studying whether a new experimental cancer study drug BAY 1000394 will
be helpful in treating solid tumor cancer with an abnormality in one of the following genes:
Mcl-1, Myc or CCNE.